Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial

NCT00868829 is registered in ClinicalTrials.gov with Shanghai MicroPort Medical (Group) Co., Ltd. as lead sponsor.

NCT NCT00868829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00868829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2009
Completion date
March 31, 2013
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease